Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Just a few months ago, we announced Class XLVII of the Stanley K. Lacy Executive Leadership Series. It is an annual tradition that applauds the role emerging leaders play in our city. It is a time of celebration and optimism. But what many people may not know, is that SKL was born out of tragedy. In 1973, Stanley K. Lacy, better known to his friends and family as Lucky, was a banker and enthusiastic participant in the civic landscape of Indianapolis.
By Jill Lacy, MD, and Michael Cecchini, MD May 25, 2022 Esophageal cancer is associated with significant morbidity and mortality worldwide, with more than 600,000 new cases and 540,000 deaths in 2020. The squamous cell histology comprises nearly 90% of cases globally, despite its steady decline in the United States over the past 40 years.
Summary Background Treatment options for patients with unresectable locally advanced pancreatic cancer are scarce. Results from a subanalysis of the phase 3 MPACT trial in metastatic pancreatic cancer suggested potential activity of nab-paclitaxel plus gemcitabine against locally advanced pancreatic cancer. The objective of this phase 2 trial was to evaluate safety and efficacy of nab-paclitaxel plus gemcitabine in previously untreated locally advanced pancreatic cancer.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
